Until now, non-invasive heart tests, such as stress tests, provided us with very little information about chest pain. This led to consultants and doctors having to perform more invasive testing to find a diagnosis for coronary artery disease.
HeartFlow FFRCT Analysis is the first non-invasive diagnostic tool that helps doctors in diagnosing heart disease, by determining how narrow the arteries have become and the impact that this has on blood flow to the heart.
NICE Guidance issued in November 2016 recommends the use of coronary CT angiography (CTA) as a frontline test for any patient whose clinical assessment indicates atypical or atypical chest pain.
Final NICE guidance issued in February 2017 has stated:
“The case for adopting HeartFlow FFRct for estimating fractional flow reserve from coronary CT angiography is supported by the evidence. The technology is non-invasive and safe, and has a high level of diagnostic accuracy.”
How it works:
- If you are experiencing cardiac chest symptoms you will be referred for a standard CT scan, providing detailed pictures of the coronary arteries
- If these CT images show indications of disease, this will then be sent to HeartFlow to create a computerised 3D model of the coronary arteries
- Trained specialists and proven calculations with powerful computers will assess the blood flow in the arteries
- You consultant receives a digital 3D colour coded model of the blood flow, aiding in diagnosing blockages and will be able to make a diagnosis and treatment plan for you